Clinical trial · Interventional
Optimizing Pulmonary Health and Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial Combining Incentive Spirometry and Aerobic Exercise
NCT06537336CI-TRIAL-00079673completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Breast cancer survivors frequently experience diminished lung function and decreased quality of life (QoL) following radiation therapy (RT). Additionally, incentive spirometry, which encourages prolonged deep breathing, could potentially amplify lung function and QoL when paired with aerobic exercises. This study investigated the combined effect of aerobic and breathing exercises using incentive spirometry on lung function and QoL in patients with breast cancer after RT.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| lung function | Device | — | UNRESOLVED |
| QoL | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- treatment group
- description
- The patients in the treatment group underwent aerobic and volumetric incentive spirometry breathing exercises
- interventionNames
- Device: QoL
- Device: lung function
- type
- ACTIVE_COMPARATOR
- label
- control group
- description
- The control group performed only aerobic exercise.
- interventionNames
- Device: QoL
- Device: lung function
Primary outcomes (2)
- measure
- lung function
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 59 Years
Show eligibility criteria text
Inclusion Criteria: * age between 30 and 59 years; * diagnosis of histological breast cancer (AJCC Stage I to III) and completion of RT for \> 3 months; * hemoglobin level \> 10 mg/dL; * ability to comprehend verbal and written instructions; * cooperative participants, willingness to participate in the study, and ability to engage in exercises by signing an informed consent form; and * Nonreactive COVID-19 antigen swab test results. Exclusion Criteria: * cancer metastasis to the bone, lungs, or surrounding organs; * aerobic exercise and incentive spirometry breathing exercises within the last six months; * uncontrolled hypertension (blood pressure \>140/90 mmHg on antihypertensive treatment); * unstable cardiovascular diseases (including unstable angina, acute myocardial infarction, arrhythmias, severe valvular heart disease, severe arteriovenous stenosis, and decompensated congestive heart failure) determined from medical records, history, physical examination, and electrocardiograms; * uncontrolled blood sugar level (random blood sugar \>200 mg/dL or fasting blood sugar \>126 mg/dL); * acute or chronic respiratory diseases (asthma, chronic obstructive pulmonary disease, and pulmonary tuberculosis); * neuromuscular dysfunction (spinal muscular atrophy, Guillain-Barré syndrome, and multiple sclerosis); * degenerative arthritis; * physical limitations affecting stationary cycling; and * musculoskeletal disorders.
References
Publications (0)
Data not yet available
No reference posted for this study.